S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
Warren Buffett uses his annual letter to warn about Wall Street and recount Berkshire's successes
66,000% upside on tiny biotech? (Ad)
MarketBeat Week in Review – 2/19 - 2/23
Taiwan giant chipmaker TSMC opens first plant in Japan as part of key global expansion
66,000% upside on tiny biotech? (Ad)
A collection of the insights Warren Buffett offered in his annual letter Saturday
West Africa bloc lifts coup sanctions on Niger in a new push for dialogue to resolve tensions
Dividend Expert Reveals His Biggest Income Secrets… Free of Charge (Ad)
West Africa's ECOWAS bloc says it's lifting sanctions imposed on Niger over last year’s coup in a new push for dialogue
Macron booed by French farmers who blame him for not doing enough to support agriculture
S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
Warren Buffett uses his annual letter to warn about Wall Street and recount Berkshire's successes
66,000% upside on tiny biotech? (Ad)
MarketBeat Week in Review – 2/19 - 2/23
Taiwan giant chipmaker TSMC opens first plant in Japan as part of key global expansion
66,000% upside on tiny biotech? (Ad)
A collection of the insights Warren Buffett offered in his annual letter Saturday
West Africa bloc lifts coup sanctions on Niger in a new push for dialogue to resolve tensions
Dividend Expert Reveals His Biggest Income Secrets… Free of Charge (Ad)
West Africa's ECOWAS bloc says it's lifting sanctions imposed on Niger over last year’s coup in a new push for dialogue
Macron booed by French farmers who blame him for not doing enough to support agriculture
S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
Warren Buffett uses his annual letter to warn about Wall Street and recount Berkshire's successes
66,000% upside on tiny biotech? (Ad)
MarketBeat Week in Review – 2/19 - 2/23
Taiwan giant chipmaker TSMC opens first plant in Japan as part of key global expansion
66,000% upside on tiny biotech? (Ad)
A collection of the insights Warren Buffett offered in his annual letter Saturday
West Africa bloc lifts coup sanctions on Niger in a new push for dialogue to resolve tensions
Dividend Expert Reveals His Biggest Income Secrets… Free of Charge (Ad)
West Africa's ECOWAS bloc says it's lifting sanctions imposed on Niger over last year’s coup in a new push for dialogue
Macron booed by French farmers who blame him for not doing enough to support agriculture
S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
Warren Buffett uses his annual letter to warn about Wall Street and recount Berkshire's successes
66,000% upside on tiny biotech? (Ad)
MarketBeat Week in Review – 2/19 - 2/23
Taiwan giant chipmaker TSMC opens first plant in Japan as part of key global expansion
66,000% upside on tiny biotech? (Ad)
A collection of the insights Warren Buffett offered in his annual letter Saturday
West Africa bloc lifts coup sanctions on Niger in a new push for dialogue to resolve tensions
Dividend Expert Reveals His Biggest Income Secrets… Free of Charge (Ad)
West Africa's ECOWAS bloc says it's lifting sanctions imposed on Niger over last year’s coup in a new push for dialogue
Macron booed by French farmers who blame him for not doing enough to support agriculture

Haemonetics (HAE) Earnings Date, Estimates & Call Transcripts

$73.51
-1.39 (-1.86%)
(As of 02/23/2024 ET)

Earnings Summary

Upcoming
Earnings Date
May. 9Estimated
Actual EPS
(Feb. 8)
$1.04 Beat By $0.10
Consensus EPS
(Feb. 8)
$0.94
Skip Charts & View Estimated and Actual Earnings Data

HAE Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

HAE Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Haemonetics Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany Guidance
Q1 20242$0.65$0.74$0.70 
Q2 20242$0.91$0.93$0.92 
Q3 20242$0.95$0.96$0.96 
Q4 20242$0.88$0.89$0.89 
FY 20248$3.39$3.52$3.46 
Q1 20252$0.92$1.07$1.00 
Q2 20252$1.03$1.10$1.07 
Q3 20252$1.00$1.14$1.07 
Q4 20252$1.00$1.04$1.02 
FY 20258$3.95$4.35$4.15 
Q1 20261$1.05$1.05$1.05 
Q2 20261$1.09$1.09$1.09 
Q3 20261$1.18$1.18$1.18 

HAE Earnings Date and Information

Haemonetics last issued its quarterly earnings data on February 8th, 2024. The medical instruments supplier reported $1.04 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.94 by $0.10. The company earned $336.20 million during the quarter, compared to analysts' expectations of $320.84 million. Its revenue was up 10.1% compared to the same quarter last year. Haemonetics has generated $2.46 earnings per share over the last year ($2.46 diluted earnings per share) and currently has a price-to-earnings ratio of 29.9. Earnings for Haemonetics are expected to grow by 6.08% in the coming year, from $3.95 to $4.19 per share. Haemonetics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, May 9th, 2024 based off prior year's report dates.

Haemonetics Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
5/9/2024
Estimated)
------- 
2/8/2024Q4 2023$0.94$1.04+$0.10$1.47$320.84 million$336.20 million      
11/2/2023Q2 2024$0.94$0.99+$0.05$1.50$319.18 million$318.18 million
8/8/2023Q2 2023$0.73$1.05+$0.32$1.30$292.74 million$311.30 million      
5/11/2023Q4 2023$0.68$0.77+$0.09$0.97$284.53 million$304.42 million
2/7/2023Q3 2023$0.79$0.85+$0.06$1.06$300.47 million$305.30 million      
11/7/2022Q2 2023$0.70$0.83+$0.13$1.02$273.92 million$297.49 million
8/10/2022Q1 2023$0.53$0.58+$0.05$0.78$249.00 million$261.50 million      
5/10/2022Q4 2022$0.60$0.65+$0.05$1.11$257.11 million$265.00 million    
2/8/2022Q3 2022$0.75$0.84+$0.09$1.23$265.40 million$259.77 million    
11/9/2021Q3 2021$0.61$0.60($0.01)$0.91$240.85 million$239.90 million    
8/10/2021Q2 2021$0.45$0.50+$0.05$1.09$225.54 million$228.53 million      
5/13/2021Q1 2021$0.67$0.46($0.21)$1.14$223.92 million$225.00 million  












Haemonetics Earnings - Frequently Asked Questions

When is Haemonetics's earnings date?

Haemonetics has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, May 9th, 2024 based off last year's report dates. Learn more on HAE's earnings history.

Did Haemonetics beat their earnings estimates last quarter?

In the previous quarter, Haemonetics (NYSE:HAE) reported $1.04 earnings per share (EPS) to beat the analysts' consensus estimate of $0.94 by $0.10. Learn more on analysts' earnings estimate vs. HAE's actual earnings.

How can I listen to Haemonetics's earnings conference call?

The conference call for Haemonetics's latest earnings report can be listened to online. Listen to Conference Call

How can I read Haemonetics's conference call transcript?

The conference call transcript for Haemonetics's latest earnings report can be read online. Read Transcript

How can I view Haemonetics's earnings report?

Haemonetics's earnings report can be found in their filing with the SEC. View SEC filing

How much revenue does Haemonetics generate each year?

Haemonetics (NYSE:HAE) has a recorded annual revenue of $1.17 billion.

How much profit does Haemonetics generate each year?

Haemonetics (NYSE:HAE) has a recorded net income of $115.40 million. HAE has generated $2.46 earnings per share over the last four quarters.

What is Haemonetics's price-to-earnings ratio?

Haemonetics (NYSE:HAE) has a trailing price-to-earnings ratio of 29.88 and a forward price-to-earnings ratio of 18.61. The price/earnings-to-growth ratio is 1.9.

What is Haemonetics's EPS forecast for next year?

Haemonetics's earnings are expected to grow from $3.95 per share to $4.19 per share in the next year, which is a 6.08% increase.


More Earnings Resources from MarketBeat

This page (NYSE:HAE) was last updated on 2/25/2024 by MarketBeat.com Staff